SURFACEPREP UK LIMITED
Company number 13536703 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SURFACEPREP UK LIMITED - Analysis Report
Company Number: 13536703
Analysis Date: 2025-07-20 17:46 UTC
Financial Health Assessment: SURFACEPREP UK LIMITED
1. Financial Health Score: D
Explanation:
The company exhibits significant financial distress symptoms, primarily characterized by negative equity and a large working capital deficit. Although there was a modest profit reported in the latest year, the underlying financial structure remains fragile. The company's role as an intermediate holding company and its dependence on group financial support moderate the risk somewhat, but the negative net asset position signals a need for remedial action to restore financial stability.
2. Key Vital Signs
| Metric | Value (2023) | Interpretation |
|---|---|---|
| Fixed Assets | £20.07 million | Strong asset base, representing long-term investments. |
| Debtors (Receivables) | £0 | No short-term receivables; typical for a holding company. |
| Current Liabilities | £22.93 million | High short-term obligations indicating liquidity pressure. |
| Net Current Assets | -£22.93 million | Deficit in working capital, a symptom of cash flow stress. |
| Total Assets Less Current Liabilities | -£2.87 million | Negative net assets indicating liabilities exceed assets. |
| Shareholders’ Funds (Equity) | -£2.87 million | Negative equity, a critical sign of financial distress. |
| Profit/(Loss) for the Year | +£274,313 | A return to profitability, mainly due to foreign exchange movements. |
Additional Context:
- The company has no turnover as it is a holding company, so operating profit is primarily influenced by foreign exchange and interest expenses.
- The negative equity and net current asset deficit indicate the company’s liabilities outstrip its assets, which is a red flag often called "balance sheet illness."
- The company benefits from continued financial support from group entities, akin to a patient on supportive care keeping vital signs stable despite underlying disease.
3. Diagnosis
Underlying Business Health:
Surfaceprep UK Limited functions as an intermediate holding company managing investments in two UK trading groups. Its financial health is heavily reliant on the financial performance and support of its subsidiaries and parent group. The negative working capital and equity position are symptoms of structural financial weakness, but the company has shown a return to profit, driven by foreign exchange gains and group funding arrangements.
The key symptom is the large short-term liability burden with no current assets to cover them, indicating liquidity risk. However, the directors' report and auditors confirm ongoing group support and no material uncertainties about going concern, suggesting the company currently has a lifeline to manage its obligations.
Risk Factors:
- Liquidity risk due to negative net current assets.
- Interest rate risk from group borrowings.
- Dependence on group financial support, which if withdrawn could exacerbate the company’s financial stress.
4. Prognosis
Future Financial Outlook:
If group support continues and subsidiaries perform well, the company’s financial health may stabilize or improve gradually. The return to profit is a positive sign, but the company needs to address its balance sheet deficits to avoid long-term viability risks. Without strengthening equity or reducing liabilities, the company remains vulnerable to external shocks or changes in group funding policies.
5. Recommendations
- Strengthen Equity Base: Consider capital injections or restructuring liabilities to reduce negative equity and improve the balance sheet health.
- Improve Working Capital Management: Although a holding company, explore opportunities to manage current liabilities more effectively, e.g., refinancing short-term debts as longer-term obligations.
- Monitor Group Funding: Maintain strong communication and agreements with group companies to ensure ongoing financial support. This is the "lifeline" that sustains current operations.
- Risk Management: Implement strategies to mitigate interest rate and foreign exchange risks associated with group borrowings and funding.
- Regular Financial Review: Institute frequent financial health checks to detect early warning signs of distress, much like regular vital sign monitoring in healthcare.
- Consider Strategic Alternatives: If group support weakens, explore options such as asset sales, restructuring, or seeking external investors to improve financial resilience.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.